INTERCEPT PHARMACEUTICALS, INC. Quarterly Return On Equity in % from Q2 2013 to Q3 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Intercept Pharmaceuticals, Inc. quarterly/annual Return On Equity history and growth rate from Q2 2013 to Q3 2023.
  • Intercept Pharmaceuticals, Inc. Return On Equity for the quarter ending September 30, 2023 was -82.2 %, a 18.5% increase year-over-year.
  • Intercept Pharmaceuticals, Inc. annual Return On Equity for 2022 was -164 %, a 433% decline from 2021.
  • Intercept Pharmaceuticals, Inc. annual Return On Equity for 2021 was 49.2 %, a 81.6% decline from 2020.
  • Intercept Pharmaceuticals, Inc. annual Return On Equity for 2020 was 268 %.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2023 -82.2 +18.7 +18.5% Jul 1, 2023 Sep 30, 2023
Q2 2023 249 +225 +939% Apr 1, 2023 Jun 30, 2023
Q1 2023 -812 -842 -2821% Jan 1, 2023 Mar 31, 2023
Q4 2022 -164 -213 -433% Oct 1, 2022 Dec 31, 2022
Q3 2022 -101 -160 -271% Jul 1, 2022 Sep 30, 2022
Q2 2022 23.9 -73.2 -75.4% Apr 1, 2022 Jun 30, 2022
Q1 2022 29.9 -125 -80.7% Jan 1, 2022 Mar 31, 2022
Q4 2021 49.2 -219 -81.6% Oct 1, 2021 Dec 31, 2021
Q3 2021 59.1 -609 -91.1% Jul 1, 2021 Sep 30, 2021
Q2 2021 97.2 +2.07K Apr 1, 2021 Jun 30, 2021
Q1 2021 154 +585 Jan 1, 2021 Mar 31, 2021
Q4 2020 268 +724 Oct 1, 2020 Dec 31, 2020
Q3 2020 668 +1.16K Jul 1, 2020 Sep 30, 2020
Q2 2020 -1.97K -1.44K -269% Apr 1, 2020 Jun 30, 2020
Q1 2020 -431 +185 +30.1% Jan 1, 2020 Mar 31, 2020
Q4 2019 -456 +135 +22.9% Oct 1, 2019 Dec 31, 2019
Q3 2019 -495 +149 +23.1% Jul 1, 2019 Sep 30, 2019
Q2 2019 -534 +78.4 +12.8% Apr 1, 2019 Jun 30, 2019
Q1 2019 -616 -42.2 -7.35% Jan 1, 2019 Mar 31, 2019
Q4 2018 -591 -323 -121% Oct 1, 2018 Dec 31, 2018
Q3 2018 -644 -468 -265% Jul 1, 2018 Sep 30, 2018
Q2 2018 -613 -478 -353% Apr 1, 2018 Jun 30, 2018
Q1 2018 -574 -465 -429% Jan 1, 2018 Mar 31, 2018
Q4 2017 -268 -167 -165% Oct 1, 2017 Dec 31, 2017
Q3 2017 -177 -97.2 -123% Jul 1, 2017 Sep 30, 2017
Q2 2017 -135 -72.4 -115% Apr 1, 2017 Jun 30, 2017
Q1 2017 -108 -58.1 -115% Jan 1, 2017 Mar 31, 2017
Q4 2016 -101 -63.3 -168% Oct 1, 2016 Dec 31, 2016
Q3 2016 -79.3 -45.2 -132% Jul 1, 2016 Sep 30, 2016
Q2 2016 -62.8 -23.6 -60.1% Apr 1, 2016 Jun 30, 2016
Q1 2016 -50.4 -24.4 -93.7% Jan 1, 2016 Mar 31, 2016
Q4 2015 -37.8 +143 +79.1% Oct 1, 2015 Dec 31, 2015
Q3 2015 -34.1 +183 +84.3% Jul 1, 2015 Sep 30, 2015
Q2 2015 -39.2 +292 +88.2% Apr 1, 2015 Jun 30, 2015
Q1 2015 -26 +868 +97.1% Jan 1, 2015 Mar 31, 2015
Q4 2014 -180 -103 -133% Oct 1, 2014 Dec 31, 2014
Q3 2014 -217 -114 -111% Jul 1, 2014 Sep 30, 2014
Q2 2014 -332 -240 -260% Apr 1, 2014 Jun 30, 2014
Q1 2014 -894 Jan 1, 2014 Mar 31, 2014
Q4 2013 -77.4 Oct 1, 2013 Dec 31, 2013
Q3 2013 -103 Jul 1, 2013 Sep 30, 2013
Q2 2013 -92.1 Apr 1, 2013 Jun 30, 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.